佳兆業健康(00876.HK)2024年度營收1.85億港元 淨虧損4640萬港元
格隆匯3月24日丨佳兆業健康(00876.HK)公佈年度業績,集團錄得收益約1.85億港元,較2023財年輕微減少0.3%。於2024年度,公司股權持有人應占虧損約4640萬港元(2023年:溢利約750萬港元)。每股基本虧損為0.92港仙。
集團從事齒科業務,包括於海外和本地銷售及生產義齒,包括牙冠及牙橋,可拆式之全部及部份義齒、植體及金屬牙冠。集團自主研發,鼎力打造的高科技數位美牙品牌,整合了全球優秀的微創牙科美容修復理念、3D列印前沿技術,推廣隱形矯正,牙齒美容美白、牙貼面,提供高效一站式牙齒修復解決方案,截至2024年12月31日,來自齒科業務之收益約為1.79億港元,較2023財年收益約1.794億港元減少約40萬港元。減少由於受國家集採政策影響產品售價下降所致。
集團研發方向一直秉承着「微創不傷牙」的美學修復理念,讓患者在美牙過程中減輕痛苦,輕鬆變美。二零一九年旗下品牌推出的美加貼面XS,美加3D模擬鋯,美加易齊透明矯正器,活動義齒等系列數位化義齒產品,獲得了海內外技師和牙醫的極大認可。
集團業務一向致力投資於研究及專門知識。於2024年12月31日的研發費用約1250萬港元,持續投入研發費用反映管理層就齒科業務投資未來科技之決心及願景。另一方面,於2024年12月31日的政府補助約90萬港元。
2024年,深圳市成為全國首評12座國家級「全民健身運動模範市(區)」之一,政府進一步推動全民健身,體衞融合,運動康復市場進一步穩定增長,在此利好政策影響下,更多社會資本看好運動康復產業,進入該賽道參與競爭。和佳康復門診部在二零二四年進行內部經營調整,進一步推進降本增效,2024年業務實現顯著增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.